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Abstract. L-ascorbic acid 2-phosphate (LAA) is known to induce chondrocyte 
differentiation. The objective of this study was to analyze the potency of LAA in 
chondrogenic differentiation of adipose-derived mesenchymal stem cells 
(ADSC) by analyzing the glycosaminoglycans (GAG) content and type II 
collagen (Coll2) localization. ADSC was characterized using flow cytometry and 
cultured in media containing various concentrations of LAA (0, 25, 50, 100 
μg/mL) for 2, 3 and 4 weeks. Coll2 localization was analyzed by 
immunocytochemistry (ICC) using a confocal microscope. The quantification of 
GAG was performed by Alcian Blue staining and calcium deposition by Alizarin 
Red S staining. The results showed that ADSC was positive for mesenchymal 
stem cell (MSC) markers. Coll2 was localized in the cytoplasm and showed 
increasing abundance along with the increase of the LAA concentration. The 
highest intensity of Coll2 localization was shown in LAA 100 μg/mL. ADSC in 
LAA induction medium showed higher GAG content compared to the control 
group (LAA 0 μg/mL) (p < 0.05). The highest calcium deposit was shown by 
LAA 25 μg/mL after 4 weeks of culture (p < 0.05) and it decreased at higher 
concentrations. In conclusion, LAA 100 μg/mL is considered the optimum LAA 
concentration for chondrogenic differentiation. 
Keywords: chondrocyte; chondrogenesis; collagen II; glycosaminoglycan; L-ascorbic 
acid 2-phosphate. 
1 Introduction 
Articular cartilage is a specialized connective tissue that is numerously found in 
diarthrodial joints. The major function of articular cartilage is to enable smooth 
movement and provide lubricated surfaces to ease movement [1]. Articular 
cartilage is mainly composed of chondrocytes and various components of the 
extracellular matrix. Chondrocytes are the only resident cells present in articular 
cartilage and play a significant role in providing mechanical support and are 
also a major functional component to support joint movement [2].  
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GAG and Coll2 are the two largest extracellular matrix components synthesized 
and maintained by mature chondrocytes [1]. GAG are negatively charged 
complex molecules that form by linear polysaccharides with molecular weight 
ranges from 10 to 100kDa. GAG interacts with various proteins in the 
extracellular matrix (ECM), including proteoglycan, the most abundant protein. 
Collagen is a structural protein that serves as the major component of 
connective tissue. There are 8 kinds of collagen based on its structure. Coll2 and 
type XI collagen are fibril-forming collagen and are dominantly found in 
articular cartilage [3].   
Articular cartilage is avascular and has low capacity of self-repair. Thus, once 
cartilage tissues have been damaged, it is difficult for them to heal. Damage in 
articular cartilage impairs joint movement with a significant impact on daily 
activities and in some cases may have more severe effects such as changes in 
body morphology. Currently, autologous chondrocyte implantation is widely 
used as a therapy in cartilage damage and regenerative medicine. However, this 
method of treatment involves a surgical procedure to obtain a large number of 
chondrocytes and it is invasive to the patient [4]. Therefore, the relatively high 
amounts of chondrocytes needed in cell-based therapy could be supplied by 
producing chondrocytes in vitro through chondrogenic differentiation induction 
of MSC. In this research, MSC derived from adipose tissue, called adipose-
derived mesenchymal stem cells, were used in chondrogenic differentiation 
induction in conjunction with a potential activator.  
ADSC are an important material in therapeutic applications because of their 
self-renewal and multipotent capacity. There are several advantages of using 
ADSC in therapeutic applications. For example, they are easy to obtain since 
they come from liposuction waste and provide high numbers of stem cells 
compared to bone-marrow derived stem cells [5]. In this research, a non-protein 
chemical compound, L-ascorbic acid 2-phosphate (LAA), was used as an 
alternative activator. LAA, a stable form of vitamin C, is an essential 
micronutrient and promising activator because it exhibits a stimulating effect 
that is comparable to that of other activators. Based on previous studies, LAA 
has a potential effect on ADSC proliferation, chondrogenic and osteogenic 
differentiation. In addition, LAA is much cheaper than established growth 
factors that are usually added in chondrogenic differentiation, such as TGF-β 
superfamily [6,7]. 
Chondrogenesis is a differentiation process of progenitor cells to chondrocytes 
and is an early stage of endochondral ossification. The advanced stage of 
endochondral ossification is osteogenesis, or bone formation. Endochondral 
ossification happens in 5 stages [8]. The 1st to the 4th stage are part of 
chondrogenesis, i.e. condensation of differentiated MSC, differentiation into 
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chondrocytes, maturation of ECM, and hypertrophy. These 4 stages occur from 
the 5th up to the 50th day of culture. During hypertrophy, calcification starts to 
occur as an early event of osteogenesis. During chondrogenic events there are 
changes in ECM component secretion, depending on the time of culture. mRNA 
of Coll2 is expressed in the 1st week of culture. The time determination of 
chondrogenic evaluation in this research was based on the timeline of 
chondrogenesis [8,9]. It has been found previously that GAG accumulation 
starts after 2 weeks of culture, therefore, we observed the localization of Coll2 
of cells cultured for 2 weeks. 
The objective of this research was to evaluate the potency of various 
concentrations of LAA for chondrogenic differentiation of ADSC through 
quantification of GAG content and Coll2 localization as chondrogenic markers. 
In addition, quantification of calcium deposition was also performed to confirm 
the presence of hypertrophic chondrocytes, which is a transition stage between 
chondrogenesis and osteogenesis in endochondral ossification. 
2 Materials and Methods 
2.1 Cell Culture and Expansion 
ADSC was obtained from the Hayandra Clinical Laboratory (Jakarta, 
Indonesia). The cells (2nd-3rd passage) were expanded by culturing in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, 11885084) 
supplemented with 10% Fetal Bovine Serum (FBS) (Gibco, 10270106) and 1% 
antibiotic (penicillin/streptomycin) (Lonza, 17-602E). The cell culture was 
incubated at 37 °C and 5% CO2.  The culture medium was replaced every 2 days 
[10]. The cells were characterized before proceeding to the experimental steps. 
There were four experimental groups, including one control group and three 
groups for chondrogenic induction using various LAA concentrations (25, 50, 
and 100 µg/ml).  
2.2 Mesenchymal Stem Cell  Characterization 
ADSC characterization was performed to confirm that the ADSC used in this 
research complied with the MSC criteria through analysis of the cluster of 
differentiation (CD) markers’ expression using a flow-cytometer (MACSQuant 
Analyzer 10, Miltenyi Biotec). The cells were stained by BD StemflowTM 
hMSC Analysis Kit components (CD90 FIT C, CD105 PerCP-Cy5, CD73 APC, 
CD34 PE, CD116 PE, CD19 PE, CD45 PE, HLA-DR PE and CD44 PE) (BD 
stem flowTMkit, 562245) (BD stem flowTMkit, 56224). The procedures were 
conducted according to the manufacturer’s protocol.  
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2.3 Coll2 Localization Analysis 
To examine Coll2 localization, the cells from all experimental groups were used 
after two and three weeks of incubation using the standard manufacturer’s 
protocol of immunocytochemistry. First, the samples were fixed and 
permeabilized by 100% methanol and PBS-Tween 20 respectively. As blocking 
agent, 3% bovine serum albumin in PBS-T was used. Next, the samples were 
stained by Rabbit Polyclonal Anti-Collagen II Antibody (Abcam, ab34712), 
followed by Goat Anti-Rabbit IgG H&L Alexa Fluor 488 (Abcam, ab150077). 
DAPI (Thermofisher, D1306) was used for counterstaining. Finally, the samples 
were visualized and analyzed using a confocal microscope (Fv10i Olympus 
Confocal Microscope) available at the laboratory of the ITB-Olympus Bio 
Imaging Center, Center of Advanced Science, Institut Teknologi Bandung. 
Subsequently, semi-quantitative analysis of fluorescent images was performed 
using ImageJ [11]. 
The cells were grown on round cover slips and placed in a 3-cm culture dish. 
Localization of collagen type II was examined after 2 and 3 weeks of 
incubation. The growth medium was removed and the samples were washed 
with phosphate buffered saline (PBS, pH 7.4). The samples were fixed in 100% 
methanol at -20 °C for 20 minutes. The samples were incubated in PBS-Tween 
20 (PBS-T 0.05%) at room temperature for 10 minutes to permeabilize the cells 
and then incubated in 3% bovine serum albumin in PBS-T for 60 minutes at 
room temperature to block nonspecific binding proteins. After the blocking 
process was completed, the samples were incubated in primary antibody (1:200 
Rabbit Polyclonal Anti-Collagen II Antibody, ab34712, Abcam), followed by 
secondary antibody (1:200 Goat Anti-Rabbit IgG H&L Alexa Fluor 488, 
ab150077, Abcam). The nucleus was stained using 2.5 µg/mL DAPI 
(ThermoFisher, Massachusetts, US).  
The samples were visualized with a confocal microscope (Fv10i Olympus 
Confocal Microscope) and analyzed by the Fluoview ASW software with the 
same settings and intensity at the laboratory of the ITB-Olympus Bio Imaging 
Center, Center of Advanced Science, Institut Teknologi Bandung. The existence 
of Coll2 localization was marked by red color intensity and blue color intensity 
representing the nuclei in the immunofluorescence images. Subsequently, semi-
quantitative analysis of the fluorescence images was performed using ImageJ 
[11]. 
2.4 Glycosaminoglycans Content Assay 
A GAG content assay was performed after 3 and 4 weeks of cell incubation and 
performed based on previous research that has been done by Trujillo and Popat 
[12] with some modifications. The cells were washed with sterile PBS solution 
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and fixed using aceton:methanol (1:1). The cells were stained with 1% Alcian 
Blue 8XG (Sigma, A-3157). For quantitative measurement of GAG content, the 
samples were incubated in 400 µL of 1% sodium dodecyl sulfate (SDS) for 30 
minutes in a shaker at 100 rpm to solubilize the dye and measured at 415 nm 
using a micro-plate reader (iMark™ Microplate Absorbance Reader, BioRad).  
2.5 Calcium Deposit Assay 
A calcium deposit assay was performed based on the method from 
Tavakolinejad, et al. [13] with some modifications and was performed after 4 
weeks of cell incubation. The cells were washed with sterile PBS and fixed with 
4% paraformaldehyde. After fixation, the cells were stained with 2% Alizarin 
Red S (Sigma). For quantitative measurement of calcium deposition, the 
samples were incubated in 10% acetic acid solution for 5 minutes in a shaker at 
100 rpm to extract the dye and the absorbance was measured at 655 nm using a 
micro-plate reader (iMark™ Microplate Absorbance Reader, BioRad). 
2.6 Statistical Analysis 
Statistical analysis was performed to examine the difference between the 
experimental groups. One-way ANOVA analysis followed by a post-hoc test 
was performed using IBM SPSS to check the difference in GAG  and calcium 
levels between the groups with different LAA concentrations. Paired sample t-
test was used to confirm the difference between the periods of incubation in 
GAG measurement. A significant difference occurs when p ≤ 0.05. 
3 Results and Discussion 
3.1 Adipose-Derived Mesenchymal Stem Cell Characteristics 
According to the International Society for Cellular Therapy (ISCT) there are 3 
minimal criteria that define MSC: 1) adherence to the substrate of culture; 2) 
positive expression to CD73, CD90, CD105 and negative expression to CD14, 
CD34, CD45, and human leukcocyte antigen (HLA-DR); 3) multipotent 
capacity to differentiate into 3 lineage cells: osteocytes, chondrocytes, and 
adipocytes [14]. In this study, ADSC at passage 4 (P4) of culture was used to 
define its MSC characteristics. As shown in Figure 1, the culture of ADSC P4 
exhibited adherent characteristics (spindle-shaped and elongated), thus fulfilling 
the first criteria to define MSC. This finding is also supported by Ryu, et al. 
[15], who demonstrated that in vitro ADSC cultures form a colony and are 
spindle-shaped.  
The second criteria to define MSC is the expression of a specific surface 
antigen. This specific surface antigen expression by the cells is used to 
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distinguish MSC or in this case ADSC from other cells such as endothelium, 
hematopoietic cells, and fibroblast [16].  
 
Figure 1 Adherent morphology of ADSC P4 at ±90% confluency, 
magnification 200x. 
 
Figure 2 Analysis of antigen surface markers (CD markers) expression on 
ADSC P4 by flow cytometry. ADSC was confirmed as MSC because it was 
positive for positive markers (CD73 = 99.96%; CD90 = 90.55%; 
CD105 = 85.45%) and was negative for negative markers (CD45, CD34, CD11b, 
CD19, HLA-DR = 0.19%). 
104 Anggraini Barlian & Ni Luh Wisma Eka Yanti   
Based on the flow cytometry analysis (Figure 2), the culture of ADSC P4 
exhibited positive expression of CD73 (99.96%), CD90 (90.55%), and CD105 
(87.43%), and negative expression of CD45, CD34, CD11b, CD19, and HLA-
DR (0.19%). According to these results, the ADSC used in this research 
complied with the second criteria of MSC from Dominici, et al. [14], although 
only 87.45% of the cell population exhibited positive expression to CD105 and 
the expression of CD105 had the lowest percentage among the positive CD 
markers. This occurred because the expression of CD105 by ADSC is not stable 
and increases with the increase of the period of culture and passage [17,18]. 
Hence, CD105 is reconsidered an alternative marker to define MSC based on 
the International Federation for Adipose Therapeutics and Science and ISCT 
[19]. 
The in vitro differentiation potential to osteocyte, chondrocyte and adipocyte as 
the third criteria to define MSC has been examined in a previous study [20]. 
This revealed that ADSC was capable of differentiating into 3 different types of 
cells, i.e. osteocyte, chondrocyte, and adipocyte, that were cultured in 
osteogenic, chondrogenic, and adipogenic medium, respectively. Thus, ADSC 
used in this research can be defined and considered as MSC because it exhibited 
all minimal criteria of MSC based on Dominici, et al. [14]. 
3.2 Analysis of Collagen Type II Localization in Adipose-Derived 
Mesenchymal Stem Cells Induced by L-Ascorbic Acid 2-
Phosphate 
Coll2 localization assay in ADSC induced by LAA was performed after 2 
weeks of culture. The timeline of in vitro chondrogenesis showed that the 
expression of mRNA of Coll2 (COL2A1) starts after a week of incubation [9]. 
The immunofluorescence images (Figure 3) show that the Coll2 was localized 
in the cytoplasm or intracellular of the ADSC induced by LAA. This result 
indicates that the molecule marker for chondrogenesis did exist, but it was still 
located in the cytoplasm. This is supposedly related to biosynthesis of Coll2, 
which occurs both intracellular and extracellular [21]. This result indicates that 
procollagen accumulates in the cytoplasm of ADSC that is induced by LAA. In 
addition, the immunofluorescence images showed that the localized Coll2 was 
globular-shaped and had not formed fibers like mature collagen in ECM.   
The intensity level of Coll2 localization in each group shown in Figure 4 is 
based on the semi-quantitative analysis using the ImageJ software. The 
percentage of color intensity was increased by the rise of LAA concentrations; 
the highest intensity was shown by LAA 100 µg/mL. These findings suggest  
that LAA plays an important role in Coll2 biosynthesis in ADSC.  
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Figure 3 Coll2 localization (red) in ADSC induced by LAA 0 µg/mL (A), LAA 
25 µg/mL (B), LAA 50 µg/mL (C), and LAA 100 µg/mL (D) after 2 weeks of 
incubation, nucleus (blue). Magnification 60x, bar = 20 µm. 
 
Figure 4 Intensity level of alexa fluor 488 (Coll2) in ADSC induced LAA at 
various concentrations. 
LAA is known to play a significant role in collagen biosynthesis as a cofactor of 
prolyl and lysine hydroxylase [22,23]. The absence of LAA in the 
hydroxylation stage leads to unstable conformation of triple helix procollagen 
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chondrogenesis or chondrocyte maturation through its role in Coll2 biosynthesis 
as an important component to maintain the cartilage function together with 
chondrocytes. 
3.3 Effect of L-Ascorbic Acid 2-Phosphate on 
Glycosaminoglycans Content 
The effect of LAA on GAG content was examined by performing a GAG 
content assay in the 3rd and 4th week of incubation. Determination of 
examination time was based on the in vitro chondrogenesis timeline according 
to Yamashita, et al. [8] and Barry, et al. [9], who revealed that GAG 
accumulation starts in the 2nd week of incubation and reaches its peak after the 
4th week of incubation. A previous study, showed the GAG content of ADSC 
induced by LAA was increased from the 2nd week to the 3rd week of incubation 
[20]. The present study revealed that the GAG content still increased from the 
3rd week to the 4th week, as can be seen in Figure 5.  
 
Figure 5 Quantitative GAG content assay for different LAA concentrations (0, 
25, 50, and 100 µg/mL of LAA), the Alcian Blue absorbance values 
representative for GAG content in ADSC induced LAA after 3 and 4 weeks. The 
level of GAG content was measured in triplicate. The histograms are presented 
as mean ± standard deviation. The (#) and (*) signs indicate significant 
differences between LAA concentrations at week 3 and 4 respectively compared 
to each control group. The (**) signs indicate significant differences between 
periods of incubation. 
Figure 5 shows that LAA 25, 50, and 100 μg/mL exhibited higher GAG content 
and were statistically different (p < 0.05) compared to the control group (LAA 0 
μg/mL) in the 3rd week. This result indicates that the addition of LAA in culture 
media affected the GAG content of ADSC in the 3rd week of incubation. In the 
4th week of incubation, the GAG content increased in each experimental group, 
except in LAA 25 µg/mL. The most significance increase of GAG content was 
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shown by LAA 100 µg/mL (p < 0.05). In contrast, the increase of GAG content 
in LAA 50 µg/mL was not significant (p > 0.05).  
The increase of GAG content from the 3rd to the 4th week of incubation indicates 
that the production of GAG components was still occurring. According to 
Yamashita, et al. [8], the GAG content had increased by the 4th week of 
incubation. They also explained that the maturation of ECM components 
including GAG lasts until the 6th week of incubation [8]. The results revealed 
that LAA increased the GAG content of ADSC culture induction for 4 weeks 
and the highest increase was demonstrated by LAA 100 µg/mL. 
3.4 Effect of L-Ascorbic Acid 2-Phosphate on Calcium Deposition 
in the 4th Week 
Calcium deposition indicates a mineralization process that also serves as a sign 
for hypertrophic chondrocyte and it is an early process of osteogenesis [24,25]. 
Hypertrophic chondrocyte is a transition process between chondrogenesis and 
osteogenesis in endochondral ossification. Calcium deposition started in the 4th 
week of incubation [7]. Therefore, a calcium deposit assay was performed in 
this study to examine the hypertrophic chondrocyte in ADSC induced by LAA 
after 4 weeks of incubation (Figure 6).  
 
Figure 6 Quantitative calcium deposit assay from Alizarin Red S staining in 
ADSC cultured at different LAA concentrations (0, 25, 50, and 100 µg/mL of 
LAA) after 4 weeks of incubation. The level of calcium deposition was measured 
in triplicate. The histograms are presented as mean ± standard deviation. The 
data were analyzed with ANOVA and continued with a Tukey post-hoc test. The 
(*) signs indicate significant differences between treatments and the control 
group. 
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Figure 6 represents the level of calcium deposition. Based on the result, the 
highest calcium deposit was shown by LAA 25 µg/mL. The difference is 
statistically significant (p < 0.05) compared to the other groups, whereas the 
calcium deposit was lower at a higher concentration of LAA. 
There are several studies that examined the role of LAA in calcium deposition 
as an early sign of mineralization and osteogenesis. Tayhan, et al. [26] revealed 
that osteogenic differentiation of ADSC was the best in 50 µM (±14.7 µg/mL) 
of LAA, evaluated by Alizarin Red S and Von-Kossa staining. Jaiswal, et al. 
[27] found that the best concentration of LAA in osteogenic differentiation of 
bone marrow-mesenchymal stem cells (BM-MSC) was also 50 µM; the 
differentiation was evaluated by the expression of alkaline phosphatase (ALP). 
ALP is an enzyme that plays a significant role in the formation of bone matrix 
in osteogenesis and is closely linked to the calcium deposition process [24,28]. 
However, calcium deposition caused by the increase of ALP activity influenced 
by LAA could not be explained in this study because further examination of 
ALP expression is required.  
Based on these results, it is suspected that a lower LAA concentration (25 
µg/mL) promotes calcium deposition, which is a marker of hypertrophic 
chondrocyte and the initial process of osteogenesis. Meanwhile, a higher 
concentration of LAA (100 µg/mL) promotes the increase of GAG content and 
Coll2 localization, which are important markers of chondrogenesis. This implies 
that the addition of various LAA concentrations in ADSC culture in this study 
was related to GAG content and calcium deposition. This research confirmed 
that a higher concentration of LAA compared to previous works [20] was able 
to induce chondrogenic differentiation of ADSCs on a polystyrene surface. 
However, further study is required to better know and explain the relationship 
between GAG content and calcium deposition with addition of LAA. Moreover, 
this study suggests that the use of LAA 100 µg/mL provides the best yield for 
ADSC chondrogenesis in polystyrene during 4 weeks of induction based on the 
highest chondrogenic marker expression and the lowest hypertrophic 
chondrocytes marker expression of this concentration. 
4 Conclusion 
LAA at a concentration of 100 µg/mL yielded the highest glycosaminoglycans 
and type II collagen content in the chondrogenic differentiation induction of 
ADSCs. 
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